GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

Yahoo Finance • 3 days ago

SA Asks: How could Trump's new executive order impact vaccine makers?

[Merck & Co. headquarters in Silicon Valley] Sundry Photography/iStock Editorial via Getty Images Earlier this month, President Donald Trump announced an executive order aimed at changing the number and timing of vaccines recommended for... Full story

Yahoo Finance • 5 days ago

Lawmakers ask FDA to scrutinize Chinese trials amid deaths - report

[capsules showcases the flag of United State of America and China] * Two Republican congressmen are asking FDA Acting Commissioner Kyle Diamantas to place greater scrutiny on clinical trial data from China, including not accepting data... Full story

Yahoo Finance • 7 days ago

Trump expected to nominate White House aide Heidi Overton as FDA commissioner

[FDA Headquarters] President Donald Trump is expected to tap Heidi Overton, a top aide at the White House’s Domestic Policy Council, to serve as the next commissioner of the Food and Drug Administration, according to multiple media report... Full story

Yahoo Finance • 12 days ago

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm's total Q2 turnover reached £8.4 billion, marking a 5% increas... Full story

Yahoo Finance • 14 days ago

U.K. regulator reaffirms safety of childhood vaccination

[Syringe drawing liquid medication from medical vial] zhikun sun/iStock via Getty Images Days after President Donald Trump ordered major changes to the U.S. childhood immunization schedule, the U.K. drug regulator on Wednesday reaffirmed... Full story

Yahoo Finance • 19 days ago

Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More

Company Logo Opportunities center on frontline immunotherapy combinations, biomarker and companion diagnostics, AI-enabled pathology, minimally invasive screening, precision therapies for uterine sarcomas, and tele-oncology expansion in u... Full story

Yahoo Finance • 22 days ago

ViiV Healthcare Launches "Do It For Future You" Campaign Inspiring People to Prioritize Their Sexual Health and Future

New campaign empowers people to talk to their doctor about long-acting injectable options for HIV prevention and treatment Information and resources for people living with HIV and those who could benefit from PrEP are available now at ForF... Full story

Yahoo Finance • 22 days ago

More Biotech M&A Is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector. Continue Reading... Full story

Yahoo Finance • 24 days ago

Top global market stories from this week as earnings drive sentiment

US stock indexes ended the week higher as global rally in semiconductor stocks and renewed optimism over the artificial intelligence trade lifted investor sentiment. Investors evaluated corporate earnings, interest rate trajectories, and e... Full story

Yahoo Finance • 27 days ago

GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline ...

This article first appeared on GuruFocus. Revenue: Q2 sales up 5% to more than GBP8.4 billion. Core Operating Profit: Grew 7%. Core Earnings Per Share (EPS): Up 9%. Cash Generation: Positive at GBP4.3 billion. Q2 Dividend: 17p. Gross Marg... Full story

Yahoo Finance • 28 days ago

FTSE 100 sets new record ahead of US rate call

The FTSE 100 posted solid gains on Wednesday after earlier hitting a new all-time high, lifted by well-received earnings and gains in BP and Shell as the oil price strengthened. The FTSE 100 index closed up 37.39 points, 0.3%, at 10,908.4... Full story

Yahoo Finance • 29 days ago

Earnings tonic boosts FTSE 100 as oil falls back

The FTSE 100 made strong progress on Tuesday, buoyed by positive earnings and a drop in the oil price, which helped shrug off worries sparked by a chip sector sell-off in Asia. The FTSE 100 index closed up 89.27 points, 0.8%, at 10,871.02... Full story

Yahoo Finance • 29 days ago

GSK Q2 2026 earnings beat: £1.9B cost-savings plan launched

GSK unveiled a cost-reduction initiative on Tuesday with a target of £1.9 billion in annual savings by 2029, channeling those resources toward late-stage pipeline expansion while cushioning the business against an approaching patent cliff... Full story

Yahoo Finance • 29 days ago

GSK launches $2.5 billion savings drive to boost drug pipeline

July 28 (Reuters) - GSK on Tuesday launched a £1.9 billion ($2.52 billion) cost-savings program to ‌help fund the British drugmaker's late-stage ‌studies, aiming to deliver on CEO Luke Miels' promise ​of faster drug development and boost i... Full story

Yahoo Finance • 30 days ago

Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight

The food allergy market landscape is advancing through a robust clinical pipeline, with key programs being developed by companies such as DBV Technologies (Viaskin [DBV712] Peanut Patch), Novartis (Remibrutinib), Aravax (PVX108), ALK-Abell... Full story

Yahoo Finance • last month

Earnings week ahead: AAPL. MSFT, AMZN, META, XOM, PYPL, CVX, F, KO, ABBV, V, QCOM, BA, MO, SOFI, and more

[Business Person Reviewing Quarterly Report During Meeting in Office Setting] As earnings season reaches one of its busiest and most consequential weeks, investors will be watching a broad lineup of corporate bellwethers spanning technolo... Full story

Yahoo Finance • last month

U.S. measles cases exceed 2025 total to reach highest in 35 years

[Measles disease. Health concept, Infectious, viral diseases. Vaccination of children against measles. close up] The Centers for Disease Control and Prevention on Friday updated its tally of measles infections, indicating that the U.S. ha... Full story

Yahoo Finance • last month

Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data

(RTTNews) - This week, the healthcare sector saw multiple U.S FDA and European Commission approvals, strategic licensing and M&A activity, as well as pivotal clinical trial readouts and regulatory setbacks. Positive data readouts spanned... Full story

Yahoo Finance • last month

Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.

Gilead stock is closely tied to its HIV treatments. But with Biktarvy's patent expirations looming, can the giant survive? Continue Reading... Full story

Yahoo Finance • last month

GSK's Jemperli hits goal in phase 2 trial for rectal cancer

[Colorectal cancer,medical illustration.3d illustration] ChrisChrisW * GSK (GSK [https://seekingalpha.com/symbol/GSK]) said that interim results from the phase 2 AZER-1 trial showed that patients with a certain type of rectal cancer giv... Full story